Shorts were warned yesterday to cover their position. Live and learn pansies!
Live and learn!
retire, you've done a great job establishing your reputation on this board for all to see. You're mother would be very proud of you.
IMO, very little downside here remaining, but such much upside yet to be seen. 2016/2017 will be a very good couple years for OPK, and by 2020, I believe $8.23 will be nothing more than a daily swing in the share price if it is not bought out by a PFE type company first.
Thanks for responding to my post, Burn. As you know, I've got mad respect for you, and your posts about Opko, Array, etc. I know you do your due diligence before you make a post and then sprinkle it with your own opinions. I really appreciate that.
As you know, I have been a faithful Opko follower for several years now, and we have chatted many times about the future of the company that I believe will be nothing short of being Dr. Phillip Frost's "swan song". Will he sell to Pfizer? I believe maybe he will one day, but not until the upcoming catalysts (Rayaldee, HGH, 4Kscore) have been established in it's revenue stream giving a more appropriate share price value. If Rayaldee turns out to be the blockbuster that it is forcasted to be, then I do believe Opko gets bought out before the next blockbuster Oxyntomodulin reaches phase III.
So, yes, I did go "all in" with OPK. I felt, given current market conditions, coupled with Opko's upcoming catalysts, that it was the safest place to invest with limited downside exposure and potential high rewards over the next coming months, or even years.
Is there other values in the market now? Absolutely! CSCO, BAC, C, NOV, COP, BOX, FEYE, RF, HBAN, TWTR, ETE, KMI, etc., etc., etc., are screaming buys to me at these levels, but none have the short term/long term upside that I feel Opko has.
I would love to be able to call the bottom on oil and grab some blue chips in that sector, but oil is just way to volitile now and has been for a while. Now that Iran has the go ahead to bring its oil to market, oil does not look like it is going to find a floor, let alone stabalize in the near future. My best hope is Opko triples from its current price before oil starts trending back up so I can reestablish a more diversified portfolio again.
Best of luck to you this upcoming year, Burn. I will see you over at Uncles board under my id billcollector.
Sentiment: Strong Buy
Was looking for just one stock to "park" my money until the market subsides and oil stabalizes. Opko, at least to me, looks like the safest bet considering the abundent pipeline, CEO buys, and pending FDA approvals. Opko is extremely oversold at these levels.
Sentiment: Strong Buy
There may never be a better opportunity to get in and go long, or cover that short position if you are still foolish enough to have one on at this price. In a few years, when most products have come to market, I can see Opko splitting into two separate companies. One being diagnostics, and the other being pharmaceuticals.
Sentiment: Strong Buy
You can interpret it how you will, but I specifically asked if the 4Kscore test was covered and the answer was yes, the test is covered...twice.
Me (3:25 PM):
Can you tell me the overall cost for the test? What is actually covered under the insurance?
Anthem (3:26 PM):
No sir I can not quote you a cost for the testing.
Me (3:26 PM):
Anthem (3:26 PM):
Once the provider submits the claim it will go for pricing and our allowed amounts will be entered.
Anthem (3:27 PM):
It will have to go to the local BCBS of the state you live in for the pricing.
Me (3:27 PM):
But 4Kscore is a covered test under my plan? I just was wondering what the overall price would be and how much I would have to pay total if I were to elect to get the test done.
Anthem (3:28 PM):
Yes it is covered.
Me (3:28 PM):
Thank you for taking the time for me today.
Welcome to Anthem Chat, this is Anthem, your Anthem Health Guide. I look forward to assisting you.
Me (3:13 PM):
Hello. I was looking for information on whether the 4KScore test was covered under my plan?
I will be happy to look that up for you.
Anthem (3:14 PM):
Anthem (3:16 PM):
Give me one second while I pull up your benefits.
What is this test for?
Me (3:17 PM):
psa-prostate cancer screening without biopsy.
give me one moment.
It's a blood test
Your benefits state that prostate cancer screenings including digital rectal exam and PSA test are covered at 100%
Me (3:21 PM):
Do you know if the 4Kscore test is covered?
Is this a routine screening or is it medical?
At this time, I'm just checking if the 4Kscore test is covered. It's just a simple blood test that incorporates a panel of four kallikrein protein biomarkers (total PSA, free PSA, intact PSA, and human kallikrein.
Ok, since this will be considered a diagnostic test it will apply to your benefits.
Me (3:24 PM):
I'm not interested in getting the test just yet, but I am getting to the age where I need to think about it and was wondering if this new test is covered.
You have a $300 deductible. once that's met we cover at 90/10 up to your OOP max of $2100
Yes the test is covered and it will apply to your diagnostic benefits.
I'm the source. I spoke to Anthem today and they are covering 90/10 for the 4Kscore test as a diagnostic. $300 deductible applies.
so I'm down 12.56%. If it tests $3.50, I will double down again without hesitation.
There is just way too much potential upside for this company that has partners funding most of the work. With the cash they have on hand and phase III trials underway with results expected shortly, why would anyone think about selling here?
My understanding is some funds have to liquidate if the pps falls under $5, so that could explain the recent selling. I'm just a small time retail investor, but I see this as a golden opportunity with a company that has a pipeline bursting at the seems.
Back in February this year, this stock hit $8.59, what's changed? Not much. The pipeline is still intact.
Agreed. Almost pulled the trigger and double up when it got to .305. Curious stock that got hit with a partial FDA hold but never recovered when hold was lifted. Little if any debt and recent 10% staff reduction saving $2 million and several phase 2's. Don't understand why this is not higher.